Zhu Wei, Ouyang Ping, Kong Mengnan
School of Economics and Management, Jiangxi Polytechnic University, China.
School of Economics and Management, Jiujiang Vocational and Technical College, China.
Heliyon. 2024 Jul 2;10(13):e33959. doi: 10.1016/j.heliyon.2024.e33959. eCollection 2024 Jul 15.
Under the impetus of the new industrial revolution, how to realize intelligent manufacturing transformation of traditional pharmaceutical manufacturing enterprises has realistic urgency. The study starts from the perspective of complex adaptive system, constructs a system dynamics model of the evolution mechanism of intelligent manufacturing transformation of pharmaceutical manufacturing enterprises based on technological adaptation and evolutionary adaptation, and analyzes it by simulation using Vensim PLE software. The results of the study show that pharmaceutical manufacturing enterprises utilize technological affordances to provide support to realize network product-based manufacturing capability and smart product-based manufacturing capability through technological innovation capability and institutional optimization capability; the technological affordances environment promotes the realization of intelligent manufacturing transformation of pharmaceutical manufacturing enterprises to present a stage transformation law. The study enriches and extends the research paradigm of intelligent manufacturing transformation, and provides a reference for pharmaceutical manufacturing enterprises to realize intelligent manufacturing transformation.
在新工业革命的推动下,传统制药企业如何实现智能制造转型具有现实紧迫性。该研究从复杂适应系统的视角出发,构建了基于技术适应和进化适应的制药企业智能制造转型演化机制的系统动力学模型,并运用Vensim PLE软件进行仿真分析。研究结果表明,制药企业利用技术可供性,通过技术创新能力和制度优化能力提供支持,以实现基于网络产品的制造能力和基于智能产品的制造能力;技术可供性环境推动制药企业智能制造转型的实现呈现阶段性转变规律。该研究丰富和拓展了智能制造转型的研究范式,为制药企业实现智能制造转型提供了参考。